Skip to main content
All lobbying filings

BLOUNT STRATEGIC INITIATIVES

BLOUNT STRATEGIC INITIATIVES filed a Q4 report for MYRIAD GENETICS, INC. on January 12, 2026, reporting $10,000 in lobbying income.

Lobbying for MYRIAD GENETICS, INC. · Myriad is a genetic testing and precision medicine company.

All filings by BLOUNT STRATEGIC INITIATIVES · Everything MYRIAD GENETICS, INC. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 12, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues relating to veterans' depression and the Genesight product.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem